80 filings
Page 2 of 4
8-K
ilowi9b
8 May 19
Foamix Reports First Quarter 2019 Financial Results and Provides Corporate Update
6:02am
8-K
jd51dwl1j icm
11 Apr 19
Departure of Directors or Certain Officers
6:11am
8-K
781 puznxf78
7 Mar 19
Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline
4:13pm
8-K
r9s85w1
28 Feb 19
Foamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update
4:26pm
8-K
s6w8pglg
24 Jan 19
Foamix Announces Appointment of Sharon Barbari to Board of Directors
8:00am
8-K
zolv27q
3 Jan 19
Departure of Directors or Certain Officers
4:04pm
8-K
uwdee7 u6k66
19 Nov 18
Foamix Announces Appointment of Anthony Bruno to Board of Directors
4:05pm
8-K
gvdo8
7 Nov 18
Foamix Reports Third Quarter 2018 Financial Results and Provides Corporate Update
5:22pm
8-K
mmcqe
1 Oct 18
Foamix Announces Additional Positive Topline Results from Third
5:21pm
8-K
amumm spo
18 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
5pf2kfsc iv7lohtl796
12 Sep 18
Regulation FD Disclosure
12:00am
8-K
axpjwji5 mpqrj
27 Jun 18
Foamix Announces Dosing of Last Patient in Phase 3 Rosacea
1:24pm
8-K
tn9kk34sn1qp16dkh
14 May 18
Submission of Matters to a Vote of Security Holders
4:04pm
8-K
eho6v
9 May 18
Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
8:18am
8-K
j8nwn7rwmgvfdzaq
7 May 18
Foamix Announces Dosing of Last Patient in Third Phase 3 Acne
8:01am
8-K
qirs6 9kny5b2
16 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
c7for rcua48r068jre
29 Mar 18
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
8-K
556x8c1t3l
29 Jan 18
Other Events
12:00am
8-K
6la1r4yl2dmwj1dpes
8 Jan 18
Regulation FD Disclosure
12:00am
8-K
l993i gq1
4 Jan 18
Foamix Announces Positive Results from Phase 3 Open-Label
12:00am